Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessThe DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Abstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“DNMT3a and DNMT3b were soon after identified from searching EST databases and were proposed as being the enzymes responsible for de novo methylation (25).”
BackgroundA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · cited 1×
“The use of epigenomic technologies for different acetylation and methylation modifications of histones (71,72) and methylated DNA (51,52) in embryonic stem cells provides a chromatin signature of pluripotent cell lines.”
BackgroundCpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 3×
“Although the majority of these are associated with ‘house-keeping’ genes, half of the ‘tissuespecific’ genes also contain a promoter CpG island (19).”
BackgroundInfluentialRAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 701–725 of 725
Kumar, S., Hashmi, A. S., Kumar, P., Yadav, S., Dwivedi, S., Singh, P. K., Singh, Y. R., & Sadashiv (2025) · Indian Journal of Precision Medicine and Molecular Medicine · doi:10.4103/ijpmmm.ijpmmm_2_25
Nakamura, H., Kondo, Y., Shimizu, M., Takahashi, R., & Mori, T. (2021) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/lbkhfysqjg
Lee, S., & Jeong, I. G. (2026) · Journal of Urologic Oncology · doi:10.22465/juo.265200040001
“By contrast, promoter hypermethylation leads to transcriptional silencing of tumor-suppressor genes by impairing transcription factor binding or by recruiting methyl-binding proteins and histone deacetylase complexes [19].”
Addou-Klouche, L. (2011) · theses.fr (ABES) · doi:10.70675/082349a1za09dz495fzacc4z6ad4775402d6 · Cited by 1
Epigenetic modifications, heterochromatic gene expression and DNA replication in ICF syndrome
Lana, E. (2011) · theses.fr (ABES) · doi:10.70675/a5764a59za557z4ae8zafa9z9488740c12f2
Recherche de nouvelles protéines humaines se liant à l'ADN méthylé
Joulie, M. (2011) · theses.fr (ABES) · doi:10.70675/b7745f08z7318z4dabz948bz462ab663bc37
Analyse bioinformatique des mécanismes de régulation durant le développement précoce des cellules T
Benoukraf, T. (2010) · theses.fr (ABES) · doi:10.70675/260bcf44zc16cz4493za40fzc98794a09935 · Cited by 1
Lemacon, D. S. (2014) · theses.fr (ABES) · doi:10.70675/7fd8b535z1f0cz4646zb10eze941144f55e2
Régulation épigénétique du gène CFTR
Bergougnoux, A. (2013) · theses.fr (ABES) · doi:10.70675/96be3b9czbd0az4803za18ez9f92e5e10e5c
Théron, E. (2017) · theses.fr (ABES) · doi:10.70675/d76b18c1zc2c1z4748z9fc2zcc393afc2a86
Développement de stratégies innovantes pour cibler la méthylation de l’ADN dans les cancers
Serhouni, A. (2021) · theses.fr (ABES) · doi:10.70675/1f974c7cz0d1dz4afezbbdcz8577cc5f65bd
Zhu, J., Kong, F., Guo, D., Zhang, T., Yang, Z., & Yang, T. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218559
Rewiring cancer cell fate toward vasculogenic mimicry: from classical to unconventional processes
Méndez-Pérez, E. A., García‐Quiroz, J., Avila, E., García-Becerra, R., & Díaz, L. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10356-9
“Besides microRNAs, transcriptional silencing can occur through different epigenetic reprogramming mechanisms, including DNA methylation and histone modifications [152].”
Saeda, K., Nakagawa, T., Okabe, A., Kita, K., Kurokawa, T., Fukuyo, M., Ueda, H., Seki, M., Rahmutulla, B., Yonekura, S., et al. (2026) · Cancer Science · doi:10.1111/cas.70482
“Although we and other groups have reported DNA methylation-based biomarkers associated with prognosis and recurrence risk across various cancer types, the functional relevance of the methylated genes themselves remains insufficiently characterized [23–25].”
Interplay between DNA and RNA methylation shapes cancer cell plasticity
Bove, G., Chianese, U., Beato, A., Gaudio, N. D., Benedetti, R., & Altucci, L. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.07.003
A multi-layer framework for computational cancer epigenomics
Srivastava, M., Kumar, P., Chouhan, A., Maan, K., Singh, S., Banerjee, M., & Kushwah, A. S. (2026) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen8483
Íñiguez-Muñoz, S., Bedoya-López, A. F., Ensenyat-Méndez, M., Llinàs‐Arias, P., Ahn, S. K., Factor, R. E., Marzese, D. M., & DiNome, M. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177901
“DNAm at promoters is one well-established mechanism of gene regulation and is frequently altered during tumor progression [21].”
BindingDB Entry 50006069: Polyamine-based small molecule epigenetic modulators.
BindingDB (2020) · UC San Diego · doi:10.7270/q2sx6h67
Kim, S., & Jazwinski, S. M. (2015) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6678-8_8 · Cited by 1
Benton, G. (2010) · DigitalGeorgetown (Georgetown University Library)
A demethylation screen identifies novel targets of epigenetic regulation in lung cancer
O’Leary, K. (2014) · University of Brighton Repository (University of Brighton)
Dynamics of DNA methylation in differentiating hematopoietic cells
Klug, M. (2010) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.13429 · Cited by 2
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.